Free Trial

BriaCell Therapeutics (BCTXW) Short Interest Ratio & Short Volume

BriaCell Therapeutics logo
$0.10 +0.00 (+0.10%)
As of 09:36 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BriaCell Therapeutics Short Interest Data

BriaCell Therapeutics (BCTXW) has a short interest of 1,600 shares. This marks a -15.79% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 100,619 shares to cover all short positions.

Current Short Interest
1,600 shares
Previous Short Interest
1,900 shares
Change Vs. Previous Month
-15.79%
Dollar Volume Sold Short
$185.60
Short Interest Ratio
0.0 Days to Cover
Last Record Date
February 15, 2025
Today's Trading Volume
200 shares
Average Trading Volume
100,619 shares
Today's Volume Vs. Average
0%
Short Selling BriaCell Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for BriaCell Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BCTXW Short Interest Over Time

BCTXW Days to Cover Over Time

BCTXW Percentage of Float Shorted Over Time

BriaCell Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/15/20251,600 shares $185.60 -15.8%N/A0 $0.12
1/31/20251,900 shares $318.63 -61.2%N/A0 $0.17
1/15/20254,900 shares $833.00 +53.1%N/A0 $0.17
12/31/20243,200 shares $926.40 +10.3%N/A0 $0.29
12/15/20242,900 shares $1,168.41 -77.3%N/A0 $0.40
11/30/202412,800 shares $5,529.60 +341.4%N/A0.1 $0.43
11/15/20242,900 shares $775.17 +3.6%N/A0 $0.27
10/31/20242,800 shares $867.72 -80.1%N/A0 $0.31
10/15/202414,100 shares $4,792.59 +422.2%N/A0.1 $0.34
9/30/20242,700 shares $1,107.00 +575.0%N/A0 $0.41
9/15/2024400 shares $75.84 -87.5%N/A0 $0.19
8/31/20243,200 shares $913.28 +52.4%N/A0 $0.29
8/15/20242,100 shares $376.74 +950.0%N/A0 $0.18
7/31/2024200 shares $39.04 -88.2%N/A0 $0.20
7/15/20241,700 shares $238.00 -69.6%N/A0 $0.14
6/30/20245,600 shares $1,505.84 +60.0%N/A0.1 $0.27
6/15/20243,500 shares $1,399.65 -79.3%N/A0.1 $0.40
5/31/202416,900 shares $8,788.00 +16,800.0%N/A0.3 $0.52
5/15/2024100 shares $73.00 -95.8%N/A0 $0.73
4/30/20242,400 shares $2,184.00 +300.0%N/A0.1 $0.91
4/15/2024600 shares $672.00 No ChangeN/A0 $1.12
3/31/2024600 shares $816.00 -81.3%N/A0 $1.36
3/15/20243,200 shares $4,829.76 -22.0%N/A0.3 $1.51
2/29/20244,100 shares $7,585.00 +70.8%N/A0.4 $1.85
2/15/20242,400 shares $3,575.76 +140.0%N/A0.2 $1.49
1/31/20241,000 shares $1,780.00 -47.4%N/A0.1 $1.78
1/15/20241,900 shares $3,800.00 -50.0%N/A0.2 $2.00
12/31/20233,800 shares $9,500.00 +100.0%N/A0.3 $2.50
12/15/20231,900 shares $3,325.00 +375.0%N/A0.2 $1.75
11/30/2023400 shares $900.00 -60.0%N/A0 $2.25
11/15/20231,000 shares $1,630.00 +42.9%N/A0.1 $1.63
10/31/2023700 shares $707.00 -87.7%N/A0 $1.01
10/15/20235,700 shares $8,379.00 +185.0%N/A0.3 $1.47
9/30/20232,000 shares $4,940.00 +11.1%N/A0.1 $2.47
9/15/20231,800 shares $4,374.00 -76.3%N/A0.1 $2.43
8/31/20237,600 shares $19,760.00 -20.0%N/A0.4 $2.60
8/15/20239,500 shares $24,320.00 +4,650.0%N/A0.5 $2.56
7/31/2023200 shares $500.00 -88.2%N/A0 $2.50
7/15/20231,700 shares $4,250.00 No ChangeN/A0.1 $2.50
6/30/20231,700 shares $4,250.00 +54.6%N/A0.1 $2.50
77 Hedge Funds Are Betting On This Off-Radar Mineral (Ad)

With surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fact, 77 hedge funds have quietly increased their positions, pouring millions into companies poised to capitalize on this essential commodity. The reason is simple: America currently depends on Canada for 80% of its potash supply.

6/15/20231,100 shares $2,959.00 +450.0%N/A0.1 $2.69
5/31/2023200 shares $490.00 -87.5%N/A0 $2.45
5/15/20231,600 shares $4,320.00 -65.2%N/A0.2 $2.70
4/30/20234,600 shares $13,869.00 -13.2%N/A0.3 $3.02
4/15/20235,300 shares $15,635.00 +12.8%N/A0.3 $2.95
3/31/20234,700 shares $13,912.00 -25.4%N/A0.3 $2.96
3/15/20236,300 shares $18,711.00 -13.7%N/A0.4 $2.97
2/28/20237,300 shares $22,338.00 +55.3%N/A0.4 $3.06
2/15/20234,700 shares $15,792.00 -9.6%N/A0.3 $3.36
1/31/20235,200 shares $15,548.00 +26.8%N/A0.4 $2.99
1/15/20234,100 shares $10,454.59 +310.0%N/A0.3 $2.55
12/30/20221,000 shares $2,059.90 -58.3%N/A0.1 $2.06
12/15/20222,400 shares $5,160.00 +166.7%N/A0.3 $2.15
11/30/2022900 shares $1,800.00 +200.0%N/A0.1 $2.00
11/15/2022300 shares $642.00 -25.0%N/A0 $2.14
10/31/2022400 shares $1,108.00 -69.2%N/A0 $2.77
10/15/20221,300 shares $3,965.00 -18.8%N/A0.1 $3.05
9/30/20221,600 shares $4,592.00 No ChangeN/A0.1 $2.87
9/15/20221,600 shares $6,079.84 -50.0%N/A0.1 $3.80
8/31/20223,200 shares $11,936.00 +128.6%N/A0.2 $3.73
8/15/20221,400 shares $4,200.00 -46.2%N/A0.1 $3.00
7/31/20222,600 shares $7,410.00 +73.3%N/A0.2 $2.85
7/15/20221,500 shares $3,870.00 No ChangeN/A0.1 $2.58
6/30/20221,500 shares $3,900.00 -28.6%N/A0.1 $2.60
6/15/20222,100 shares $5,838.00 -25.0%N/A0.1 $2.78
5/31/20222,800 shares $6,412.00 +180.0%N/A0.1 $2.29
5/15/20221,000 shares $2,300.00 -79.6%N/A0 $2.30
4/30/20224,900 shares $17,149.51 +188.2%N/A0.2 $3.50
4/15/20221,700 shares $7,293.00 -71.2%N/A0.1 $4.29
3/31/20225,900 shares $0.00 +168.2%N/A0.3 $0.00

BCTXW Short Interest - Frequently Asked Questions

What is BriaCell Therapeutics' current short interest?

Short interest is the volume of BriaCell Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 15th, investors have sold 1,600 shares of BCTXW short. Learn More on BriaCell Therapeutics' current short interest.

Is BriaCell Therapeutics' short interest increasing or decreasing?

BriaCell Therapeutics saw a decrease in short interest during the month of February. As of February 15th, there was short interest totaling 1,600 shares, a decrease of 15.8% from the previous total of 1,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($25.81 billion), iShares 20+ Year Treasury Bond ETF ($10.38 billion), MicroStrategy Incorporated ($7.74 billion), AppLovin Co. ($6.32 billion), Apollo Global Management, Inc. ($5.97 billion), Super Micro Computer, Inc. ($4.89 billion), Charter Communications, Inc. ($4.52 billion), Capital One Financial Co. ($3.94 billion), Schlumberger Limited ($3.19 billion), and Reddit, Inc. ($3.01 billion). View all of the most shorted stocks.

What does it mean to sell short BriaCell Therapeutics stock?

Short selling BCTXW is an investing strategy that aims to generate trading profit from BriaCell Therapeutics as its price is falling. BCTXW shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against BriaCell Therapeutics?

A short squeeze for BriaCell Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BCTXW, which in turn drives the price of the stock up even further.

How often is BriaCell Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCTXW, twice per month. The most recent reporting period available is February, 15 2025.




This page (NASDAQ:BCTXW) was last updated on 3/4/2025 by MarketBeat.com Staff
From Our Partners